Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M; SENIORS Investigators.

Eur J Heart Fail. 2009 Sep;11(9):872-80. doi: 10.1093/eurjhf/hfp104. Epub 2009 Aug 1.

3.

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.

Del Sindaco D, Tinti MD, Monzo L, Pulignano G.

Clin Interv Aging. 2010 Dec 3;5:381-93. doi: 10.2147/CIA.S4482. Review.

4.

Nebivolol for heart failure in the elderly.

Tavazzi L.

Expert Rev Cardiovasc Ther. 2007 May;5(3):423-33. Review.

PMID:
17489667
5.

Nebivolol: a review of its use in the management of hypertension and chronic heart failure.

Moen MD, Wagstaff AJ.

Drugs. 2006;66(10):1389-409; discussion 1410. Review.

PMID:
16903772
6.

Nebivolol for the treatment of heart failure.

Riva N, Lip GY.

Expert Opin Investig Drugs. 2011 Dec;20(12):1733-46. doi: 10.1517/13543784.2011.625011. Epub 2011 Oct 8. Review.

PMID:
21980961
7.

Nebivolol: third-generation beta-blockade.

de Boer RA, Voors AA, van Veldhuisen DJ.

Expert Opin Pharmacother. 2007 Jul;8(10):1539-50. Review.

PMID:
17661735
8.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
9.

[Role of the L-arginine/nitric oxide system in the action of nebivolol].

Brodde OE, Philipp T.

Dtsch Med Wochenschr. 2006 Nov 10;131(45):2545-50. Review. German.

PMID:
17091442
10.
11.

[Nebivolol: a beta blocker with vasodilator properties].

Waeber B.

Praxis (Bern 1994). 2000 Apr 6;89(15):631-3. Review. French.

PMID:
10804847
12.

Nebivolol: impact on cardiac and endothelial function and clinical utility.

Toblli JE, DiGennaro F, Giani JF, Dominici FP.

Vasc Health Risk Manag. 2012;8:151-60. doi: 10.2147/VHRM.S20669. Epub 2012 Mar 13. Review.

13.

Nebivolol: a review.

Cockcroft J.

Expert Opin Pharmacother. 2004 Apr;5(4):893-9. Review.

PMID:
15102571
14.

The role of the new beta-blockers in treating cardiovascular disease.

Weber MA.

Am J Hypertens. 2005 Dec;18(12 Pt 2):169S-176S. Review.

PMID:
16373195
15.

Nebivolol: new therapy update.

Sule SS, Frishman W.

Cardiol Rev. 2006 Sep-Oct;14(5):259-64. Review.

PMID:
16924166
16.

Pharmacology of nebivolol.

Mangrella M, Rossi F, Fici F, Rossi F.

Pharmacol Res. 1998 Dec;38(6):419-31. Review.

PMID:
9990650
17.

Nebivolol: a review of its clinical and pharmacological characteristics.

Gielen W, Cleophas TJ, Agrawal R.

Int J Clin Pharmacol Ther. 2006 Aug;44(8):344-57. Review.

PMID:
16961165
18.

The role of vasodilating beta-blockers in patients with complicated hypertension: focus on nebivolol.

Giles TD.

Am J Med. 2010 Jul;123(7 Suppl 1):S16-20. doi: 10.1016/j.amjmed.2010.04.014. Review.

PMID:
20609694
19.

beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

Dobre D, Haaijer-Ruskamp FM, Voors AA, van Veldhuisen DJ.

Drugs Aging. 2007;24(12):1031-44. Review.

PMID:
18020535
20.

Nitric oxide mechanisms of nebivolol.

Maffei A, Lembo G.

Ther Adv Cardiovasc Dis. 2009 Aug;3(4):317-27. doi: 10.1177/1753944709104496. Epub 2009 May 14. Review.

PMID:
19443516

Supplemental Content

Support Center